abstract |
The invention relates to an anesthetic composition containing anhydrous fluoroether compound and a physiologically acceptable Lewis acid inhibitor (eg water, butylated hydroxygen, methylparaben, propofol, thymol). This composition has improved stability and is not degradable in the presence of Lewis acid. |